Published in Ann Neurol on May 01, 1991
Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol (2007) 1.27
Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol (2007) 1.23
Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. PLoS One (2011) 0.87
Glial adenosine kinase--a neuropathological marker of the epileptic brain. Neurochem Int (2013) 0.84
The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine. Front Mol Neurosci (2016) 0.82
Comorbidities in Neurology: Is adenosine the common link? Neuropharmacology (2015) 0.80
Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy. Gene Ther (2014) 0.79
Adenosinergic signaling in epilepsy. Neuropharmacology (2015) 0.78
High mobility group box 1 enhances hyperthermia-induced seizures and secondary epilepsy associated with prolonged hyperthermia-induced seizures in developing rats. Metab Brain Dis (2017) 0.75
Adenosine receptors in brain: neuromodulation and role in epilepsy. Ann Neurol (1989) 1.67
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med (1999) 2.78
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev (1995) 1.81
Neuroprotective effects of adenosine. Trends Pharmacol Sci (1988) 1.69
The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev (1998) 1.64
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience (2000) 1.55
The role of immediate early genes in the stabilization of long-term potentiation. Mol Neurobiol (1991) 1.41
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun (1992) 1.39
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther (2001) 1.34
Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience (1993) 1.26
CREB phosphorylation promotes nerve cell survival. J Neurochem (1999) 1.24
A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience (1999) 1.22
The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience (2005) 1.21
Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res (1995) 1.20
Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol (1999) 1.13
Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res (1998) 1.09
Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience (2001) 1.06
Is adenosine an endogenous anticonvulsant? Epilepsia (1985) 1.02
The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair. Brain Res Mol Brain Res (1996) 1.02
Doublecortin expression in the normal and epileptic adult human brain. Eur J Neurosci (2008) 1.02
Correlation between the induction of an immediate early gene, zif/268, and long-term potentiation in the dentate gyrus. Brain Res (1992) 1.01
Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum. Neuroscience (1998) 1.01
Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res (1996) 1.00
Krox20 may play a key role in the stabilization of long-term potentiation. Brain Res Mol Brain Res (1995) 0.99
Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Brain Res Rev (1999) 0.99
Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study. Neuroscience (1990) 0.96
First human hNT neurons patterned on parylene-C/silicon dioxide substrates: Combining an accessible cell line and robust patterning technology for the study of the pathological adult human brain. J Neurosci Methods (2010) 0.93
Neurochemical and morphological changes associated with human epilepsy. Brain Res Brain Res Rev (1995) 0.92
Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. Neuroreport (1994) 0.91
Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res Mol Brain Res (1993) 0.91
Loss of Ref-1 protein expression precedes DNA fragmentation in apoptotic neurons. Brain Res Mol Brain Res (1997) 0.91
Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42). Neuroscience (2010) 0.90
GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels. Neuroscience (1990) 0.89
Autoradiographic localisation of NMDA, quisqualate and kainic acid receptors in human spinal cord. Neurosci Lett (1990) 0.89
Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res (1997) 0.89
Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience (1993) 0.89
Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res (1996) 0.88
Immediate early gene expression associated with the persistence of heterosynaptic long-term depression in the hippocampus. Proc Natl Acad Sci U S A (1994) 0.88
The toxicity of 6-hydroxydopamine on PC12 and P19 cells. Brain Res Mol Brain Res (1999) 0.88
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease. Br J Pharmacol (2010) 0.88
Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res Mol Brain Res (1994) 0.87
L-dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur J Pharmacol (1989) 0.87
CCAAT-enhancer binding protein alpha is expressed in activated microglial cells after brain injury. Brain Res Mol Brain Res (1998) 0.86
Differential expression of immediate early genes after hippocampal long-term potentiation in awake rats. Brain Res Mol Brain Res (1993) 0.86
Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel. Neurotoxicology (2007) 0.86
Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp Neurol (1997) 0.86
No change in progenitor cell proliferation in the hippocampus in Huntington's disease. Neuroscience (2011) 0.84
Immediate early gene transcription and synaptic modulation. J Neurosci Res (1999) 0.84
High-frequency discharge of dentate granule cells, but not long-term potentiation, induces c-fos protein. Brain Res (1988) 0.84
Induction of Fos-like immunoreactivity and the maintenance of long-term potentiation in the dentate gyrus of unanesthetized rats. Brain Res Mol Brain Res (1990) 0.84
Annexin V labels apoptotic neurons following hypoxia-ischemia. Neuroreport (1997) 0.84
Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Neurosci Lett (2006) 0.84
Brain-derived neurotrophic factor is induced as an immediate early gene following N-methyl-D-aspartate receptor activation. Neuroscience (1993) 0.84
ATF-2 phosphorylation in apoptotic neuronal death. Brain Res Mol Brain Res (1998) 0.83
Expression of immediate early gene proteins following axotomy and inhibition of axonal transport in the rat central nervous system. Neuroscience (1993) 0.83
Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience (1994) 0.83
Adenosine modulation of amygdala kindling. Exp Neurol (1984) 0.82
Induction of the Krox 24 transcription factor in striosomes by a cannabinoid agonist. Neuroreport (1995) 0.82
Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro. Neuroreport (1999) 0.82
Excitatory amino acid receptors in the human cerebral cortex: a quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine, L-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites. Neuroscience (1989) 0.82
Seizure-inducible c-fos protein(s) in mammalian neurons. Trends Pharmacol Sci (1988) 0.81
Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis. Neuroscience (2005) 0.81
A population of PC12 cells that is initiating apoptosis can be rescued by nerve growth factor. Mol Cell Neurosci (2001) 0.81
Induction of clusterin in the immature brain following a hypoxic-ischemic injury. Brain Res Mol Brain Res (1996) 0.81
Presence of c-fos-like immunoreactivity in the adult rat brain. Eur J Pharmacol (1987) 0.81
Focal brain injury increases activin betaA mRNA expression in hippocampal neurons. Neuroreport (1997) 0.81
PU.1 expression in microglia. J Neuroimmunol (2000) 0.81
Analysis of the decremental nature of LTP in the dentate gyrus. Brain Res Mol Brain Res (1995) 0.80
Localisation of the adenosine uptake site in the human brain: a comparison with the distribution of adenosine A1 receptors. Brain Res (1996) 0.80
Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons. Brain Res Mol Brain Res (1994) 0.80
MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurones. Neuroreport (1993) 0.80
The mitogen-activated/extracellular signal-regulated kinase kinase 1/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells. Neuroscience (2006) 0.80
Prostaglandin H synthase-2 and cytosolic phospholipase A2 in the hypoxic-ischemic brain: role in neuronal death or survival? Brain Res Mol Brain Res (1997) 0.79
Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus. Brain Res Mol Brain Res (1997) 0.79
Adult neurogenesis in mesial temporal lobe epilepsy: a review of recent animal and human studies. Curr Pharm Biotechnol (2007) 0.79
Effects of hypoxia-ischemia and seizures on neuronal and glial-like c-fos protein levels in the infant rat. Brain Res (1990) 0.79
Basal expression of Fos, Fos-related, Jun, and Krox 24 proteins in rat hippocampus. Brain Res Mol Brain Res (1992) 0.79
The regional, cellular and subcellular localization of GABAA/benzodiazepine receptors in the substantia nigra of the rat. Neuroscience (1992) 0.79
Temporal relationship between the expression of fos, jun and krox-24 in the guinea pig vestibular nuclei during the development of vestibular compensation for unilateral vestibular deafferentation. Brain Res (1996) 0.79
Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins. Brain Res (1991) 0.78
GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease. Neuroscience (1995) 0.78
[3H]glycine binding sites, NMDA and PCP receptors have similar distributions in the human hippocampus: an autoradiographic study. Brain Res (1989) 0.78
Differential expression of inducible transcription factors in basal ganglia neurons. Brain Res Mol Brain Res (1995) 0.78
MK-801 sensitizes rats to pilocarpine induced limbic seizures and status epilepticus. Neuroreport (1993) 0.78
Autoradiographic distribution of sigma receptors in human neocortex, hippocampus, basal ganglia, cerebellum, pineal and pituitary glands. Brain Res (1991) 0.78
Autoradiographic visualisation of [3H]DTG binding to sigma receptors, [3H]TCP binding sites, and L-[3H]glutamate binding to NMDA receptors in human cerebellum. Neurosci Lett (1991) 0.77
Do c-Jun, c-Fos, and amyloid precursor protein play a role in neuronal death or survival? J Neurosci Res (1998) 0.77
Medial septal cholinergic neurons express c-Jun but do not undergo DNA fragmentation after fornix-fimbria transections. Brain Res Mol Brain Res (1996) 0.77
Etoposide-induced PC12 cell death: apoptotic morphology without oligonucleosomal DNA fragmentation or dependency upon de novo protein synthesis. Brain Res Mol Brain Res (1997) 0.77
Endogenous anticonvulsant substances. Neurosci Biobehav Rev (1986) 0.77
Non-NMDA glutamate receptors are involved in the maintenance of status epilepticus. Neuroreport (1993) 0.77
Neuronal injury following electrically induced status epilepticus with and without adenosine receptor antagonism. Exp Neurol (1995) 0.77
The distribution of neurotensin receptors and acetylcholinesterase in the human caudate nucleus: evidence for the existence of a third neurochemical compartment. Brain Res (1989) 0.77
Unilateral vestibular deafferentation induces brain-derived neurotrophic factor (BDNF) protein expression in the guinea pig lateral but not medial vestibular nuclei. J Vestib Res (1999) 0.76
Cycloheximide phase-shifts, but does not prevent, de novo Krox-24 protein expression. Neuroreport (1997) 0.76
Differential regulation by MK801 of immediate-early genes, brain-derived neurotrophic factor and trk receptor mRNA induced by a kindling after-discharge. Brain Res Mol Brain Res (1998) 0.76
trkC may be an inducible transcription factor target gene. Neuroreport (1995) 0.76
NMDA and kainic acid receptors have a complementary distribution to AMPA receptors in the human cerebellum. Brain Res (1990) 0.76